Skip Nav Destination
Close
Article navigation
Education|
July 1984
Effect of Age, Gender, and Obesity on Midazolam Kinetics
David J. Greenblatt, M.D.
;
David J. Greenblatt, M.D.
* Chief, Division of Clinical Pharmacology; Professor of Psychiatry and Associate Professor of Medicine, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
Search for other works by this author on:
Darrell R. Abernethy, M.D., Ph.D.
;
Darrell R. Abernethy, M.D., Ph.D.
* Chief, Division of Clinical Pharmacology; Professor of Psychiatry and Associate Professor of Medicine, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
Search for other works by this author on:
Ann Locniskar, B.S.
;
Ann Locniskar, B.S.
* Chief, Division of Clinical Pharmacology; Professor of Psychiatry and Associate Professor of Medicine, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
Search for other works by this author on:
Jerold S. Harmatz, B.A.
;
Jerold S. Harmatz, B.A.
* Chief, Division of Clinical Pharmacology; Professor of Psychiatry and Associate Professor of Medicine, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
Search for other works by this author on:
Raul A. Limjuco, M.D.
;
Raul A. Limjuco, M.D.
* Chief, Division of Clinical Pharmacology; Professor of Psychiatry and Associate Professor of Medicine, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
Search for other works by this author on:
Richard I. Shader, M.D.
Richard I. Shader, M.D.
* Chief, Division of Clinical Pharmacology; Professor of Psychiatry and Associate Professor of Medicine, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
† Associate Chief, Division of Clinical Pharmacology; Assistant Professor of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center. Present address: Section on Hypertension/Clinical Pharmacology, Baylor College of Medicine, Houston, Texas.
‡ Director of Analytical Laboratory, Division of Clinical Pharmacology, Tufts University School of Medicine and New England Medical Center.
§ Assistant Professor of Psychiatry, Tufts University School of Medicine and New England Medical Center.
¶ Department of Clinical Pharmacology, Hoffmann-LaRoche, Inc., Nutley, New Jersey.
** Professor and Chairman, Department of Psychiatry, Tufts University School of Medicine and New England Medical Center.
Search for other works by this author on:
Anesthesiology July 1984, Vol. 61, 27–35.
Citation
David J. Greenblatt, Darrell R. Abernethy, Ann Locniskar, Jerold S. Harmatz, Raul A. Limjuco, Richard I. Shader; Effect of Age, Gender, and Obesity on Midazolam Kinetics . Anesthesiology 1984; 61:27–35 doi: https://doi.org/10.1097/00000542-198407000-00006
Download citation file:
Close
117
Views
0
Citations
Citing articles via
Most Viewed
Related Articles
Gender Differences in Anesthesiologists' Annual Incomes
Anesthesiology (April 2007)
The Importance of Prior Stroke for the Adjusted Risk of Neurologic Injury after Cardiac Surgery for Women and Men
Anesthesiology (April 2003)
Women Emerge from General Anesthesia with Propofol/Alfentanil/Nitrous Oxide Faster than Men
Anesthesiology (May 1999)
Effects of Cardiopulmonary Bypass on Sufentanil Pharmacokinetics in Patients Undergoing Coronary Artery Bypass Surgery
Anesthesiology (October 2004)
Female Gender Associates with Increased Duration of Intubation and Length of Stay after Coronary Artery Surgery
Anesthesiology (February 2000)